Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:1683-1687
Published online before print May 20, 2004, doi: 10.1161/01.STR.0000131658.80951.c3
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/7/1683    most recent
01.STR.0000131658.80951.c3v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yip, H.-K.
Right arrow Articles by Chen, M.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yip, H.-K.
Right arrow Articles by Chen, M.-C.
Related Collections
Right arrow Acute Cerebral Infarction

(Stroke. 2004;35:1683.)
© 2004 American Heart Association, Inc.


Original Contributions

Serial Changes in Platelet Activation in Patients After Ischemic Stroke

Role of Pharmacodynamic Modulation

Hon-Kan Yip, MD; Shun-Sheng Chen, MD, PhD; Josef S. Liu, MD; Hsueh-Wen Chang, PhD; Yi-Fen Kao, MD; Min-Yu Lan, MD; Yung-Yee Chang, MD; Shung-Lon Lai, MD; Wei-Hsi Chen, MD Mien-Cheng Chen, MD

From the Division of Cardiology (H.-K.Y., M.-C.C.), Department of Neurology (J.S.L., Y.-F.K., M.-Y.L., Y.-Y.C., S.-L.L., W.-H.C.), Chang Gung Memorial Hospital, Kaohsiung; Department of Biological Sciences (S.-S.C., H.-W.C.), National Sun Yat-Sen University, Taiwan, Republic of China.

Correspondence to Mien-Cheng Chen, MD, Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, 123, Ta Pei Road, Niao Sung Hsiang, Kaohsiung Hsien, 83301, Taiwan, Republic of China. E-mail chenmien{at}ms76.hinet.net

Background and Purpose— Enhanced platelet activity has previously been reported in the acute phase after ischemic stroke. We tested the hypothesis that activated platelets (expressed by CD62p) are substantially increased in the acute stage after a stroke and decrease thereafter, and that antiplatelet therapies can suppress CD62p expression.

Methods— We serially examined platelet CD62p expression using flow cytometry after acute ischemic stroke in 87 consecutive patients. The CD62p expression was also evaluated in 20 healthy volunteers and 33 at-risk control subjects.

Results— CD62p expression was significantly higher in the acute phase after ischemic stroke than in normal and at-risk control subjects (both P<0.0001). CD62p expression decreased to a significantly lower level on day 21, and to a substantially lower level on day 90. CD62p expression was not significantly suppressed by warfarin. However, CD62p expression was significantly suppressed by aspirin treatment (P=0.024) and more substantially suppressed by clopidogrel (P<0.0001) on day 90. Furthermore, only clopidogrel treatment (P=0.0016) was significantly independently associated with decreased CD62p expression on day 90.

Conclusions— Platelet activation was significantly increased in acute ischemic stroke and substantially decreased thereafter. The lesser long-term pharmacodynamic potency of aspirin relative to clopidogrel raises the prospect of the need for more effective antiplatelet agents or a synergistic combination therapy for stroke prevention in the future.


Key Words: stroke, ischemic • platelet activation • antiplatelet therapy




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
J. Smout, A. Dyker, M. Cleanthis, G. Ford, P. Kesteven, and G. Stansby
Platelet Function Following Acute Cerebral Ischemia
Angiology, June 1, 2009; 60(3): 362 - 369.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
D.-F. Dai, P. Thajeb, C.-F. Tu, F.-T. Chiang, C.-H. Chen, R.-B. Yang, and J.-J. Chen
Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic stroke.
J. Am. Coll. Cardiol., June 3, 2008; 51(22): 2173 - 2180.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. -K. Yip, C. -H. Lu, C. -H. Yang, H. -W. Chang, W. -C. Hung, C. -I. Cheng, S. -M. Chen, and C. -J. Wu
Levels and value of platelet activity in patients with severe internal carotid artery stenosis
Neurology, March 28, 2006; 66(6): 804 - 808.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
A. LeGuyader, R. Watanabe, J. Berbe, A. Boumediene, M. Cogne, and M. Laskar
Platelet activation after aortic prosthetic valve surgery
Interactive CardioVascular and Thoracic Surgery, February 1, 2006; 5(1): 60 - 64.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
I. Kriszbacher, M. Koppan, J. Bodis, H.-K. Yip, S.-S. Chen, and M.-C. Chen
Aspirin for Stroke Prevention Taken in the Evening? * Response:
Stroke, December 1, 2004; 35(12): 2760 - 2762.
[Full Text] [PDF]